ArticleAntimicrobial agents and chemotherapy2025

Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors.

Michelle Outeda-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.